International variation in prostate cancer incidence and mortality rates.
about
Should docetaxel be standard of care for patients with metastatic hormone-sensitive prostate cancer? Pro and contraThe relationship between nutrition and prostate cancer: is more always better?Molecular mechanisms underlying resistance to androgen deprivation therapy in prostate cancerAn Estimate of the Incidence of Prostate Cancer in Africa: A Systematic Review and Meta-AnalysisDemography and disease characteristics of prostate cancer in IndiaMolecular aspects of prostate cancer with neuroendocrine differentiationProstate-Specific Antigen (PSA)-Based Population Screening for Prostate Cancer: An Evidence-Based AnalysisUrological malignancy in Hong Kong: the trend and the practiceRole of magnetic resonance imaging in defining a biopsy strategy for detection of prostate cancerValidation of proposed prostate cancer biomarkers with gene expression data: a long road to travelOncolytic adenovirus-mediated therapy for prostate cancerEpidemiology of prostate cancer in IndiaMechanisms linking excess adiposity and carcinogenesis promotionProstate cancer screening in Brazil: should it be done or not?Role of systemic chemotherapy in metastatic hormone-sensitive prostate cancerUrologic cancer in TaiwanIncidence of kidney, bladder, and prostate cancers in Korea: An updateNutrition, dietary interventions and prostate cancer: the latest evidencePre- and post-operative nomograms to predict recurrence-free probability in korean men with clinically localized prostate cancerAssociation between Seminal Vesicle Invasion and Prostate Cancer Detection Location after Transrectal Systemic Biopsy among Men Who Underwent Radical ProstatectomyPhytoestrogens and risk of prostate cancer: an updated meta-analysis of epidemiologic studies.Psycho-oncology assessment in Chinese populations: a systematic review of quality of life and psychosocial measures.In Silico Analysis of the deleterious nsSNP's (missense) in the Homeobox domain of human HOXB13 gene responsible for hereditary prostate cancer.Pomegranate Extracts in the Management of Men's Urologic Health: Scientific Rationale and Preclinical and Clinical Data.A core outcome set for localised prostate cancer effectiveness trials: protocol for a systematic review of the literature and stakeholder involvement through interviews and a Delphi survey.Prostate cancer incidence in 43 populations worldwide: An analysis of time trends overall and by age group.A review of continuous vs intermittent androgen deprivation therapy: redefining the gold standard in the treatment of advanced prostate cancer. Myths, facts and new data on a ″perpetual dispute″.Prostate cancer in South Africa: pathology based national cancer registry data (1986-2006) and mortality rates (1997-2009)3D vs 2D laparoscopic radical prostatectomy in organ-confined prostate cancer: comparison of operative data and pentafecta rates: a single cohort study.An epidemiological analysis of potential associations between C-reactive protein, inflammation, and prostate cancer in the male US population using the 2009-2010 National Health and Nutrition Examination Survey (NHANES) data.Combination of prostate imaging reporting and data system (PI-RADS) score and prostate-specific antigen (PSA) density predicts biopsy outcome in prostate biopsy naïve patients.External Evaluation of a Novel Prostate Cancer Risk Calculator (ProstateCheck) Based on Data from the Swiss Arm of the ERSPC.Involvement of apoptotic pathways in docosahexaenoic acid-induced benefit in prostate cancer: Pathway-focused gene expression analysis using RT2 Profile PCR Array System.Determining the optimal number and location of cutoff points with application to data of cervical cancer.Impact of DNA repair gene polymorphisms on the risk of biochemical recurrence after radiotherapy and overall survival in prostate cancer.Androgen synthesis inhibitors in the treatment of castration-resistant prostate cancer.Metformin and prostate cancer: reduced development of castration-resistant disease and prostate cancer mortality.Mutation of MED12 is not a frequent occurrence in prostate cancer of Korean patients.Extranodal extension of lymph node metastasis influences recurrence in prostate cancer: a systematic review and meta-analysis.Physical activity and risk of prostate and bladder cancer in China: The South and East China case-control study on prostate and bladder cancer
P2860
Q24289204-FD920E94-7717-478A-B243-7D3A790F32B0Q24604956-F60B3020-97B0-418A-A974-FE362AAAFC05Q26739708-2F4AE992-6059-4CE3-9D78-AEDD22871253Q26748679-E6F8F7BE-3B07-4FB5-BEB1-4EBCBFECB689Q26749077-8C215C0F-0ADC-4A3B-B81A-86EAF33EE219Q26752910-CCDA4929-7616-4676-90D4-2130EFF9D161Q26781093-80891601-455C-4AA5-AD9C-D6EA9C405A7EQ26785709-936E1BFC-E415-4A18-94C2-5104CB9B3BBAQ26998938-B743335B-8F76-4D2B-81F2-2479EF9E2232Q27001399-E65D1A58-E739-4C88-A2BA-590B9BFB3004Q27004796-4809A476-F8E4-414B-8FB2-247A63941683Q27021674-A4D34466-695A-46B4-91B6-2468A037BAC3Q27022929-210F8737-73A2-4608-A41B-268866D1217DQ28068688-A30979F5-E512-477E-A842-612B5D69DC42Q28076110-7A05DDD0-102E-4EE8-A1D1-848591844162Q28079868-753D6928-0EFA-4822-AC5D-7FB7077223B9Q28082161-4E5C9854-3086-492D-97E7-B70A37951F6DQ28084566-57D44215-ECA5-489E-84B0-014CD2F0E756Q28539777-035B5653-CD57-4146-A9D8-B5173F8FBEBDQ28553140-38A94D07-4856-4AE3-9FF1-D383A3757DAFQ30244993-9B7BE08E-802C-4565-971A-DA7F10D8076DQ30252103-7ED14AC9-9662-4087-8A8C-586D6B7A24EDQ30397277-16B7D92D-C372-45DE-95FB-19FD4448DFA0Q30617117-EDCE422C-0C29-4BE3-91C1-5F27197AC758Q30626731-AC5BF585-85F7-4293-A57D-5C8C32F8E9E8Q30698121-ED95AB1C-A084-42DA-ACEC-D34981E6912FQ30780322-4AFE35BA-99AB-4BAF-A1D3-3DCAF87B16F8Q30832800-CDF105AC-5F08-41EA-918C-00B1A3620446Q30936063-819E7E08-848E-4566-AD28-2BD26F8CBF05Q30994067-A6B41E28-E7E7-41D5-BA30-58CF9675DB69Q31051724-B132CD5F-1BBD-45EF-BA62-72276EB19D93Q31096808-E624E73B-C80B-423F-8433-5ABB0793497AQ32179802-59D67D76-ED2A-4AC2-B0A8-AE4A5251C7F5Q33610844-D575AD93-561A-4175-9996-F9072D46C355Q33618495-C1C1E9AB-47A0-4A27-9640-BB1D7EA8E0CAQ33621403-B3571619-FE23-471F-A143-2C545752A8FAQ33668168-9F7C233F-2BC0-4791-BCC3-187CC6D9ECE5Q33668760-8A4BD7FC-CFDB-430F-A1A8-027DE93ABE8BQ33725877-45DBC71E-DF6B-49FB-AF7D-CE3724356208Q33757541-AB3AE535-382E-486C-AC16-F9F903D06964
P2860
International variation in prostate cancer incidence and mortality rates.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
International variation in prostate cancer incidence and mortality rates.
@en
type
label
International variation in prostate cancer incidence and mortality rates.
@en
prefLabel
International variation in prostate cancer incidence and mortality rates.
@en
P2093
P1433
P1476
International variation in prostate cancer incidence and mortality rates
@en
P2093
Ahmedin Jemal
Elizabeth Ward
Jacques Ferlay
Joannie Lortet-Tieulent
Melissa M Center
Otis Brawley
P304
P356
10.1016/J.EURURO.2012.02.054
P407
P50
P577
2012-03-08T00:00:00Z